Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive cutaneous tumor that usually does not metastasize. Clinically, it may present as a reddish macule to protuberant nodule affecting the trunk and proximal extremities of young and middle-aged adults. Histologically, it is characterized by a monomorphous storiform proliferation of spindle cells, involving the dermis and hypodermis, with a honeycomb pattern of infiltration of the subcutaneous fat. In case of difficulty in diagnosis, immunohistochemical markers (especially CD34) are highly sensitive for DFSP. It is important to remember that the rarity of DFSP, its resemblance to hypertrophied scars and keloids, and its appearance at trauma sites sometimes make the diagnosis of DFSP difficult and delayed.
In the literature, DSFP was not described in a child until 1957. Here we report an instance of DFSP at an unusual site in a 9-year-old child, which was the location of a previous central venous line insertion in the left supraclavicular area. A complete excision of the tumor with a wide surgical margin of 3cm of visibly uninvolved tissue was performed, followed by a deltopectoral flap and skin split graft. Postoperatively, the patient’s general condition was stable and he was discharged after 5 days to be followed up 3 months later in our clinic.
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
No sources of funding were used to assist in the preparation of this case report. The authors have no conflicts of interest that are directly relevant to the content of this case report.
Fletcher CD, Evans BJ, MacArtney JC, et al. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985; 9 (9): 921–38PubMedCrossRefGoogle Scholar
Weiss SW. Histological typing of soft tissue tumours. 2nd ed. WHO international histological classification of tumours. Berlin: Springer, 1994Google Scholar
Escalona-Zapata J, Alvarez Fernandez E, Llorca Escuin F. The fibroblastic nature of dermatofibrosarcoma protuberans: a tissue culture and ultrastructural study. Virchows Arch A Pathol Anat Histol. 1981; 391: 165–75PubMedCrossRefGoogle Scholar
Hashimoto K, Brownstein MH Jakobiec FA. Dermatofibrosarcoma protuberans: a tumor with perineural and endoneural features. Arch Dermatol. 1974; 11: 874–5CrossRefGoogle Scholar
Diaz-Cascajo C. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant. J Cutan Pathol. 1997; 24: 197–8PubMedCrossRefGoogle Scholar
Laurier R, Wolff HH, Jones RE. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopathol. 1990; 12: 25–30CrossRefGoogle Scholar
Pedeutour F, Simon MP, Minoletti F. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996; 72: 171–4PubMedCrossRefGoogle Scholar
Pedeutour F, Lacour JP, Perrin C. Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1996; 89: 175–6PubMedCrossRefGoogle Scholar
Craver RD, Correa H, Kao Y, et al. Dermatofibrosarcoma protuberans with 46,XY,t(X;7) abnormality in a child. Cancer Genet Cytogenet. 1995; 80: 75–7PubMedCrossRefGoogle Scholar
Mandahl N, Heim S, Willen H, et al. Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990; 49: 273–5PubMedCrossRefGoogle Scholar
Green JJ, Heymann RH. Dermatofibrosarcoma protuberans occurring in smallpox vaccination scar. J Am Acad Dermatol. 2003; 48: S54–5PubMedCrossRefGoogle Scholar
Keshen TH, Cedema PS, Savell Jr VH, et al. Clinical and pathological features of pediatric dermatofibrosarcoma protuberans. Ann Plast Surg. 1995; 35: 633–7PubMedCrossRefGoogle Scholar
McKee PH, Fletcher CDM. Dermatofibrosarcoma protuberans presenting in infancy and childhood. J Cutan Pathol. 1991; 18: 241–6PubMedCrossRefGoogle Scholar
McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma protuberans: an analysis of 86 cases: five with metastasis. Ann Surg. 1967; 166: 803–16PubMedCrossRefGoogle Scholar
Burkhardt BR, Soule EH, Winkelmann RK, et al. Dermatofibrosarcoma protuberans: study of fifty-six cases. Am J Surg. 1966; 111: 638–44PubMedCrossRefGoogle Scholar
Bouyssou-Gauthier ML, Labrousse F, Longis B, et al. Dermatofibrosarcoma protuberans in childhood. Pediatr Dermatol. 1997; 14: 463–5PubMedCrossRefGoogle Scholar
Garg SK, Subbuswamy SG, Alabi JO, et al. Dermatofibrosarcoma protuberans in Northern Nigeria: a clinico-pathological review of 17 cases. Clin Oncol. 1978; 4: 113–22PubMedGoogle Scholar
Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol. 1993; 16: 154–8CrossRefGoogle Scholar
Teirrer-Lacombe MJ, Gilloub L, Maire G, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data. Am J Surg Pathol. 2003; 27 (1): 27–39CrossRefGoogle Scholar
Checketts SR, Hamilton TK, Baughman RD. Congenital and childhood dermatofibrosarcoma protuberans: a case report and review of the literature. J Am Acad Dermatol. 2000; 42: 907–13PubMedCrossRefGoogle Scholar
Schmoeckel C, Albini A, Krieg T, et al. The fibroblastic nature of dermatofibrosarcoma protuberans: morphological investigations in vivo and in vitro. Arch Dermatol Res. 1985; 278: 138–47PubMedCrossRefGoogle Scholar
Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural and immunohistochemical study. Am J Surg Pathol. 1985; 9: 630–9PubMedCrossRefGoogle Scholar
Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993; 15: 429–34PubMedCrossRefGoogle Scholar
Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 1993; 17: 1039–45PubMedCrossRefGoogle Scholar
Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993; 28: 613–7PubMedCrossRefGoogle Scholar